Will Venetoclax’s Approval Be Expanded to a Broader Group of Patients?

Will the recently approved treatment venetoclax (Venclexta) be available soon for all CLL patients? Andrew Schorr, Patient Power founder and host, asks Dr. Nicole Lamanna of Columbia University Medical Center and Dr. Philip Thompson of MD Anderson Cancer Center for their expert opinion on this recently approved medication can be used very, very well.”

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo